nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A second vaccine revolution for the new epidemics of the 21st century
|
Dyer, Mark R. |
|
2006 |
11 |
21-22 |
p. 1028-1033 6 p. |
artikel |
2 |
Data analysis of alternative splicing microarrays
|
Cuperlovic-Culf, Miroslava |
|
2006 |
11 |
21-22 |
p. 983-990 8 p. |
artikel |
3 |
Developing a paradigm of drug innovation: an evaluation algorithm
|
Caprino, Luciano |
|
2006 |
11 |
21-22 |
p. 999-1006 8 p. |
artikel |
4 |
Diagnostic challenges for multiplexed protein microarrays
|
Master, Stephen R. |
|
2006 |
11 |
21-22 |
p. 1007-1011 5 p. |
artikel |
5 |
Diary
|
|
|
2006 |
11 |
21-22 |
p. 1042- 1 p. |
artikel |
6 |
In search of sustainability: process R&D in light of current pharmaceutical industry challenges
|
Federsel, Hans-Jürgen |
|
2006 |
11 |
21-22 |
p. 966-974 9 p. |
artikel |
7 |
New aromatase inhibitors with potential in breast cancer treatment
|
Westwell, Andrew D. |
|
2006 |
11 |
21-22 |
p. 1041- 1 p. |
artikel |
8 |
Rational and efficient geometric definition of pharmacophores is essential for the patent process
|
Guérin, Georges-Alexandre |
|
2006 |
11 |
21-22 |
p. 991-998 8 p. |
artikel |
9 |
Selectins – potential pharmacological targets?
|
Kneuer, Carsten |
|
2006 |
11 |
21-22 |
p. 1034-1040 7 p. |
artikel |
10 |
Solubility: it's not just for physical chemists
|
Bhattachar, Shobha N. |
|
2006 |
11 |
21-22 |
p. 1012-1018 7 p. |
artikel |
11 |
The long and difficult road to the diagnostic market: protein microarrays
|
Joos, Thomas O. |
|
2006 |
11 |
21-22 |
p. 959-961 3 p. |
artikel |
12 |
The promise of South African biotech
|
Akermann, Britt |
|
2006 |
11 |
21-22 |
p. 962-965 4 p. |
artikel |
13 |
Towards the discovery of drug-like RNA ligands?
|
Foloppe, Nicolas |
|
2006 |
11 |
21-22 |
p. 1019-1027 9 p. |
artikel |
14 |
Vector-based RNAi approaches for stable, inducible and genome-wide screens
|
Fewell, Gwen D. |
|
2006 |
11 |
21-22 |
p. 975-982 8 p. |
artikel |